Get started
Bafna Pharmaceuticals LimitedBafna Pharmaceuticals LimitedBafna Pharmaceuticals Limited

Bafna Pharmaceuticals Limited

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsSeasonals
Full chart
Full chart

Compare with Bafna Pharmaceuticals Limited



Key stats


Market capitalization
‪9.11 B‬ INR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
115.10
Basic EPS (TTM)
3.30 INR
Net income (FY)
‪111.00 M‬ INR
Revenue (FY)
‪1.51 B‬ INR
Shares float
—
Beta (1Y)
1.17

Employees


Employees (FY)
339
Change (1Y)
−67−16.50%
Revenue / Employee (1Y)
‪4.44 M‬ INR
Net income / Employee (1Y)
‪327.43 K‬ INR

Company info


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Bansilal Mahaveer C. Bafna
Website
bafnapharma.com
Headquarters
Chennai
Founded
1981
IPO date
Jun 27, 2008
ISIN
INE878I01022
FIGI
BBG000V2CWK4
Identifiers
ISIN INE878I01022
CFI code
ESVUFN
Bafna Pharmaceuticals Ltd. engages in the manufacturing of finished pharmaceutical formulations. Its products include Anti-Infectives, Cardiovascular, Diabetes and Metabolic, Oncology, Pain and Anti-Inflammatory, CNS, and CRAMS drugs. The company was founded in 1981 and is headquartered in Chennai, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of BAFNAPH is 393.00 INR — it has increased by 1.99% in the past 24 hours. Watch Bafna Pharmaceuticals Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Bafna Pharmaceuticals Limited stocks are traded under the ticker BAFNAPH.
BAFNAPH stock has risen by 8.19% compared to the previous week, the month change is a 30.24% rise, over the last year Bafna Pharmaceuticals Limited has showed a 136.93% increase.
BAFNAPH reached its all-time high on Oct 1, 2026 with the price of 378.75 INR, and its all-time low was 4.40 INR and was reached on Mar 2, 2020. View more price dynamics on BAFNAPH chart.
See other stocks reaching their highest and lowest prices.
BAFNAPH stock is 1.96% volatile and has beta coefficient of 1.17. Track Bafna Pharmaceuticals Limited stock price on the chart and check out the list of the most volatile stocks — is Bafna Pharmaceuticals Limited there?
Today Bafna Pharmaceuticals Limited has the market capitalization of ‪9.11 B‬, it has increased by 8.21% over the last week.
Yes, you can track Bafna Pharmaceuticals Limited financials in yearly and quarterly reports right on TradingView.
BAFNAPH net income for the last quarter is ‪751.00 K‬ INR, while the quarter before that showed ‪27.49 M‬ INR of net income which accounts for 0.00% change. Track more Bafna Pharmaceuticals Limited financial stats to get the full picture.
No, BAFNAPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 6, 2026, the company has 339 employees. See our rating of the largest employees — is Bafna Pharmaceuticals Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bafna Pharmaceuticals Limited EBITDA is ‪117.61 M‬ INR, and current EBITDA margin is 10.71%. See more stats in Bafna Pharmaceuticals Limited financial statements.
Like other stocks, BAFNAPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bafna Pharmaceuticals Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bafna Pharmaceuticals Limited technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bafna Pharmaceuticals Limited stock shows the buy signal. See more of Bafna Pharmaceuticals Limited technicals for a more comprehensive analysis.